Novel isopentenyladenosine analogues: Synthesis, characterization, and evaluation of antiproliferative activity on bladder carcinoma cells

Nucleosides, Nucleotides and Nucleic Acids

Volumn 28, Issue 8, 2009, Pages 736-751

  Ottria, Roberta ^a   Casati, Silvana ^a   Maier, Jeanette A M ^a   Mariotti, Massimo ^a   Ciuffreda, Pierangela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Acyclic nucleosides; Antitumor agents; Bladder carcinoma cells; Isopentenyladenosine

Indexed keywords

2 (HYDROXYMETHYL)BUTANE 1,4 DIOL; 5 (2 HYDROXYETHYL) 2,2 DIMETHYL 1,3 DIOXANE; 6 (3 METHYL 2 BUTENYLAMINO) 9 (PROPANE 2,3 DIOL 1 YL)PURINE; 6 (3 METHYL 2 BUTENYLAMINO) 9 [4 HYDROXY 3 (HYDROXYMETHYL)BUT 1 YL]PURINE; 6 (3 METHYLBUTYL) 9 (BETA DEXTRO RIBOFURANOSYL)PURINE; 6 (3 METHYLBUTYLAMINO) 9 (PROPANE 2,3 DIOL 1 YL)PURINE; 6 (3 METHYLBUTYLAMINO) 9 [4 HYDROXY 3 (HYDROXYMETHYL)BUT 1 YL]PURINE; 6 CHLORO 9 [(2,2 DIMETHYL 1,3 DIOXAN 5 YL)ETHYL]PURINE; 6 CHLORO 9 [(2,2 DIMETHYL 1,3 DIOXOLAN 4 YL)METHYL]PURINE; ACYCLIC NUCLEOSIDE; CYTOKININ; EPIDERMAL GROWTH FACTOR; ISOPENTYLADENOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN J82; CELL STRAIN T24; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MITSUNOBU REACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DESIGN; HUMANS; ISOPENTENYLADENOSINE; MOLECULAR STRUCTURE; URINARY BLADDER NEOPLASMS;

EID: 75149161883     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770903155550     Document Type: Article

References (30)

1. Skoog, F.; Armstrong, D.J. Cytokinins. Annu. Rev. Plant Physiol. 1970, 21, 359-384.
2. Faust, J.R.; Dice, J.F. Evidence of Isopentenyladenine modification on a cell cycle-regulated protein. J. Biol. Chem. 1991, 266, 9961-9970.
3. Laezza, C.; Migliaro, A.; Cerbone, R.; Tedesco, I.; Santillo, M.; Garbi, C.; Bifulco, M. N6- Isopentenyladenosine affects cAMP-dependent microfilament organization in FRTL-5 Thyroid cells. Exp. Cell. Res. 1997, 234, 178-182(5).
4. Laten, H.M.; Zahareas-Doktor, S. Presence and source of free isopentenyladenosine in yeasts. Proc. Natl. Acad. Sci. USA 1985, 82, 1113-1115.
5. Spinola, M.; Colombo, F.; Falvella, F.S.; Dragani, T.A. N6-Isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers. Int. J. Cancer 2007, 120, 2744-2748.
6. Colombo, F.; Falvella, F.S.; De Cecco, L.; Tortoreto, M.; Pratesi, G.; Ciuffreda, P.; Ottria, R.; Santaniello, E.; Cicatiello, L.; Weisz, A.; Dragani, T.A. Pharmacogenomics and analogues of the antitumour agent N6- Isopentenyladenosine. Int. J. Cancer 2009, 124, 2179-2185.
7. 2- Isopentenyl)adenosine, a natural component of mammalian transfer RNA. Cancer Res. 1970, 30, 1429-1436.
8. Mittelman, A.; Evans, J.T.; Chheda, G.B. Cytokinins as chemotherapeutic agents. Ann. N Y Acad. Sci. 1975, 255, 225-234.
9. Harnden, M.R.; Jarvest, R.L.; Bacon, T.H.; Boyd, M.R. Synthesis and antiviral activity of 9-[4-hydroxy- 3-(hydroxymethyl)but-1-yl]purines. J. Med. Chem. 1987, 30, 1636-1642.
10. Schneider, K.C.; Benner, S.A. Oligonucleotides containing flexible nucleoside analogues. J. Am. Chem. Soc. 1990, 112, 453-455.
11. Agrofoglio, L.A.; Gillaizeau, I.; Saito, Y. Palladium-assisted routes to nucleosides. Chem. Rev. 2003, 103, 1875-1916.
12. Pathak, T. Azidonucleosides: synthesis, reactions, and biological properties. Chem. Rev. 2002, 102, 1623-1667.
13. Ichikawa, E.; Kato, K. Syntheses of oxoetanocin A and related unuasual nucleosides with bis(hydroxymethyl)-branched sugars. Synthesis 2002, 1-28.
14. Biamonte, M.A.; Shi, J.; Hong, K.; Hurst, D.C.; Zhang, L.; Fan, J.; Busch, D.J.; Karjian, P.L.; Maldonado, A.A.; Sensintaffar, J.L.; Yang, Y.-C.; Kamal, A.; Lough, R.E.; Lundgren, K.; Burrows, F.J.; Timony, G.A.; Boehm, M.F.; Kasibhatla, S.R. Orally active purine-based inhibitors of the Heat Shock Protein 90. J. Med. Chem. 2006, 49, 817-828.
15. Hasan, A.; Srivastava, P.C. Synthesis and biological studies of unsaturated acyclonucleoside analogues of S-adenosyl-L-homocysteine hydrolase inhibitors. J. Med. Chem. 1992, 35, 1435-1439.
16. Phadtare, S.; Kessel, D.; Corbett, T.H.; Renis, H.E.; Court, B.A.; Zemlicka, J. Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity. J. Med. Chem. 1991, 34, 421-429.
17. Sekiyama, T.; Hatsuya, S.; Tanaka, Y.; Uchiyama, M.; Ono, N.; Iwayama, S.; Oikawa, M.; Suzuki, K.; Okunishi, M.; Tsuji, T. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of cyclopropyl nucleoside with potent inhibitory activity against Herpesviruses. J. Med. Chem. 1998, 41, 1284-1298.
18. Vandendriessche, F.; Snoeck, R.; Janssen, G.; Hoogmartens, J.; Van Aerschot, A.; De Clercq, E.; Herdewijn, P. Synthesis and antiviral activity of acyclic nucleosides with a 3(S),5-dihydroxypentyl or 4(R)-methoxy-3(S),5- dihydroxypentyl side chain. J. Med. Chem. 1992, 35, 1458-1465.
19. Khalafi-Nezhad, A.; Soltani Rad, M.N.; Khoshnood, A. Microwave-assisted ring opening of epoxides with pyrimidine nucleobases: a rapid entry into C-nucleoside synthesis. Synthesis 2004, 583-589.
20. Khalafi-Nezhad, A.; Zarea, A.; Soltani Rad, M.N.; Mokhtari, B.; Parhami, A. Microwave-assisted Michael addition of some pirimidine and purine nucleobases with α,β-unsaturated esters: a rapid entry into carboacyclic nucleoside synthesis. Synthesis 2005, 419-424.
21. Amblard, F.; Nolan, S.P.; Schinazi, R.F.; Agrofoglio, L.A. Efficient synthesis of various acycloalkenyl derivatives of pyrimidine using cross-metathesis and Pd(0) methodologies. Tetrahedron 2005, 61, 537-544.
22. Mitsunobu, O. The use of diethyl azadicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1981, 1-28.
23. Kim, K.R.; Moon, H.R.; Park, A.-Y.; Chun, M.W.; Jeong, L.S. Design, synthesis, and biological evaluation of novel iso-D-2′,3′-dideoxy- 3′-fluorothianucleoside derivatives. Bioorg. Med. Chem. 2007, 15, 227-234.
24. V́eliz, E.A.; Beal, P.A.Mitsunobu reactions of nucleoside analogs using triisopropyl phosphate-DIAD. Tetrahedron Lett. 2006, 47, 3153-3156.
25. Yin, X.-q.; Li, W.-k.; Schneller, S.W. An efficient Mitsunobu coupling to adenine-derived carbocyclic nucleosides. Tetrahedron Lett. 2006, 47, 9187-9189.
26. Yang, M.; Zhou, J.; Schneller, S.W. The Mitsunobu reaction in preparing 3-deazapurine carbocyclic nucleosides. Tetrahedron 2006, 62, 1295-1300.
27. Dyrskjot, L.; Zieger, K.; Orntoft, T.F. Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers. Front Biosci. 2007, 12, 2063-2073.
28. Roberts, J.D.; Mazur, R.H. Small-ring compounds. IV. Interconversion reactions of cyclobutyl, cyclopropylcarbinyl and allylcarbinyl derivatives. J. Am. Chem. Soc. 1951, 73, 2509-2520.
29. Leonard, N.J.; Hecht, S.M.; Skoog, F.; Schimdts, R.Y. Cytokinins: synthesis of 6-(3-methyl-3- butenylamino)-9-β-D-ribofuranosylpurine (3iPA), and the effect of side-chain unsaturation on the biological activity of isopentylaminopurines and their ribosides. Proc. Natl. Acad. Sci. USA 1968, 59, 15-21.
30. Mariotti, M.; Castiglioni, S.; Maier, J.A.M. Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTP. Cancer Lett. 2009, 273, 155-163.